Virtus ETF Advisers’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,411
| Closed | -$64.4K | – | 659 |
|
|
2024
Q4 | $64.4K | Sell |
11,411
-5,044
| -31% | -$28.4K | 0.03% | 424 |
|
|
2024
Q3 | $79.6K | Buy |
16,455
+290
| +2% | +$1.4K | 0.04% | 414 |
|
|
2024
Q2 | $78.9K | Buy |
16,165
+10,119
| +167% | +$49.4K | 0.04% | 408 |
|
|
2024
Q1 | $80.3K | Sell |
6,046
-419
| -6% | -$5.56K | 0.04% | 393 |
|
|
2023
Q4 | $90.1K | Buy |
6,465
+683
| +12% | +$9.52K | 0.06% | 403 |
|
|
2023
Q3 | $76.7K | Sell |
5,782
-577
| -9% | -$7.65K | 0.05% | 368 |
|
|
2023
Q2 | $119K | Buy |
6,359
+1,888
| +42% | +$35.4K | 0.07% | 329 |
|
|
2023
Q1 | $64.5K | Sell |
4,471
-1,724
| -28% | -$24.9K | 0.04% | 415 |
|
|
2022
Q4 | $120K | Buy |
+6,195
| New | +$120K | 0.06% | 418 |
|